These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 10456922)

  • 1. Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae.
    Tu AH; Fulgham RL; McCrory MA; Briles DE; Szalai AJ
    Infect Immun; 1999 Sep; 67(9):4720-4. PubMed ID: 10456922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The virulence function of Streptococcus pneumoniae surface protein A involves inhibition of complement activation and impairment of complement receptor-mediated protection.
    Ren B; McCrory MA; Pass C; Bullard DC; Ballantyne CM; Xu Y; Briles DE; Szalai AJ
    J Immunol; 2004 Dec; 173(12):7506-12. PubMed ID: 15585877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface.
    Ren B; Szalai AJ; Hollingshead SK; Briles DE
    Infect Immun; 2004 Jan; 72(1):114-22. PubMed ID: 14688088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PspA and PspC minimize immune adherence and transfer of pneumococci from erythrocytes to macrophages through their effects on complement activation.
    Li J; Glover DT; Szalai AJ; Hollingshead SK; Briles DE
    Infect Immun; 2007 Dec; 75(12):5877-85. PubMed ID: 17923519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumococcal surface protein A inhibits complement deposition on the pneumococcal surface by competing with the binding of C-reactive protein to cell-surface phosphocholine.
    Mukerji R; Mirza S; Roche AM; Widener RW; Croney CM; Rhee DK; Weiser JN; Szalai AJ; Briles DE
    J Immunol; 2012 Dec; 189(11):5327-35. PubMed ID: 23105137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The absence of PspA or presence of antibody to PspA facilitates the complement-dependent phagocytosis of pneumococci in vitro.
    Ren B; Li J; Genschmer K; Hollingshead SK; Briles DE
    Clin Vaccine Immunol; 2012 Oct; 19(10):1574-82. PubMed ID: 22855389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae.
    Ren B; Szalai AJ; Thomas O; Hollingshead SK; Briles DE
    Infect Immun; 2003 Jan; 71(1):75-85. PubMed ID: 12496151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae.
    Ochs MM; Bartlett W; Briles DE; Hicks B; Jurkuvenas A; Lau P; Ren B; Millar A
    Microb Pathog; 2008 Mar; 44(3):204-14. PubMed ID: 18006268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive inhibition of complement deposition by pneumolysin and PspA facilitates Streptococcus pneumoniae septicemia.
    Yuste J; Botto M; Paton JC; Holden DW; Brown JS
    J Immunol; 2005 Aug; 175(3):1813-9. PubMed ID: 16034123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae.
    Briles DE; Yother J; McDaniel LS
    Rev Infect Dis; 1988; 10 Suppl 2():S372-4. PubMed ID: 3187321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H.
    Neeleman C; Geelen SP; Aerts PC; Daha MR; Mollnes TE; Roord JJ; Posthuma G; van Dijk H; Fleer A
    Infect Immun; 1999 Sep; 67(9):4517-24. PubMed ID: 10456894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational selection of broadly cross-reactive family 2 PspA molecules for inclusion in chimeric pneumococcal vaccines.
    Converso TR; Goulart C; Rodriguez D; Darrieux M; Leite LCC
    Microb Pathog; 2017 Aug; 109():233-238. PubMed ID: 28602840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a modified opsonophagocytic killing assay for anti-pneumococcal surface protein A antibody.
    Kuroda E; Koizumi Y; Piao Z; Nakayama H; Tomono K; Oishi K; Hamaguchi S; Akeda Y
    J Microbiol Methods; 2023 Sep; 212():106804. PubMed ID: 37543109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response.
    Ramos-Sevillano E; Urzainqui A; Campuzano S; Moscoso M; González-Camacho F; Domenech M; Rodríguez de Córdoba S; Sánchez-Madrid F; Brown JS; García E; Yuste J
    Infect Immun; 2015 Feb; 83(2):591-603. PubMed ID: 25404032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the bloodstream.
    Brown EJ; Hosea SW; Frank MM
    Rev Infect Dis; 1983; 5 Suppl 4():S797-805. PubMed ID: 6356294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumolysin, PspA, and PspC contribute to pneumococcal evasion of early innate immune responses during bacteremia in mice.
    Quin LR; Moore QC; McDaniel LS
    Infect Immun; 2007 Apr; 75(4):2067-70. PubMed ID: 17220305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Streptococcus pneumoniae Binds to Host Lactate Dehydrogenase via PspA and PspC To Enhance Virulence.
    Park SS; Gonzalez-Juarbe N; Martínez E; Hale JY; Lin YH; Huffines JT; Kruckow KL; Briles DE; Orihuela CJ
    mBio; 2021 May; 12(3):. PubMed ID: 33947761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae.
    Abeyta M; Hardy GG; Yother J
    Infect Immun; 2003 Jan; 71(1):218-25. PubMed ID: 12496169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential role of factor B of the alternative complement pathway in complement activation and opsonophagocytosis during acute pneumococcal otitis media in mice.
    Li Q; Li YX; Stahl GL; Thurman JM; He Y; Tong HH
    Infect Immun; 2011 Jul; 79(7):2578-85. PubMed ID: 21502587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae.
    Crain MJ; Waltman WD; Turner JS; Yother J; Talkington DF; McDaniel LS; Gray BM; Briles DE
    Infect Immun; 1990 Oct; 58(10):3293-9. PubMed ID: 1698178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.